← Back to Search

Exercise and Cognitive Rehabilitation for Cancer Survivors (E-Co Trial)

N/A
Recruiting
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have completed curative intent treatments
Able to walk 4 meters
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention at week 12
Awards & highlights

E-Co Trial Summary

This trial will test whether a mobile health intervention including exercise and cognitive rehabilitation can improve cognition in cancer survivors.

Who is the study for?
This trial is for cancer survivors aged 60 or older who can walk, have finished their main cancer treatments, and may still be on hormone therapy. They should not have any health issues that make exercise risky, as decided by their oncologist. Participants must speak English and score ≤10 on a cognitive impact scale.Check my eligibility
What is being tested?
The study is testing 'E-Co,' a mobile health program combining physical exercise with cognitive rehabilitation to see if it helps improve brain function in older adults who've survived cancer.See study design
What are the potential side effects?
Since this intervention involves exercise and cognitive training, side effects might include typical risks associated with physical activity such as muscle strain or fatigue. Cognitive rehab usually doesn't cause side effects but could potentially lead to frustration or mental fatigue.

E-Co Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have finished treatments aimed at curing my condition.
Select...
I can walk 4 meters by myself.
Select...
I can care for myself but may not be able to do heavy physical work.
Select...
I am 60 years old or older.

E-Co Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention at week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention at week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of the intervention
Secondary outcome measures
Cambridge Neuropsychological Test Automated Battery (CANTAB)
Controlled Oral Word Association (COWA)
Hopkins Verbal Learning Test-Revised (HVLT-R)
+1 more

E-Co Trial Design

1Treatment groups
Experimental Treatment
Group I: E-CoExperimental Treatment1 Intervention
The E-Co intervention will integrate active components of a mobile health exercise intervention (GO-EXCAP) into a cognitive rehabilitation intervention (MAAT-G).

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
840 Previous Clinical Trials
534,230 Total Patients Enrolled

Media Library

E-Co Clinical Trial Eligibility Overview. Trial Name: NCT05388214 — N/A
Cancer Research Study Groups: E-Co
Cancer Clinical Trial 2023: E-Co Highlights & Side Effects. Trial Name: NCT05388214 — N/A
E-Co 2023 Treatment Timeline for Medical Study. Trial Name: NCT05388214 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary objective of this medical experiment?

"The primary focus of this 12-week clinical trial is to gauge the feasibility of an intervention. Secondary outcomes include assessing patients' self-reported cognition using the Functional Assessment of Cancer Therapy-Cognition (FACT-Cog) survey, Controlled Oral Word Association (COWA) tool for verbal fluency and executive function evaluation, and Cambridge Neuropsychological Test Automated Battery's Delayed Matching to Sample test which assesses visual recognition memory."

Answered by AI

Are there any unoccupied positions in this clinical trial?

"According to the clinicaltrials.gov listing, this research trial is not accepting applications at present. The initial posting was on December 1st 2022 and last edited on October 8th 2022. Nevertheless, there are 486 other medical studies actively recruiting patients currently."

Answered by AI
~8 spots leftby Dec 2024